Novo Slides; Accenture Up; Arhaus Upgrade

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

• Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news.
• Arhaus (ARHS) is moving after Jefferies upgraded the furniture company to buy from hold, writing that it has “newfound optimism on the retailer’s strategy to elevate brand awareness” and improve market share.
• Accenture (ACN) is up on news Anthropic is partnering with Accenture to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations.

See omnystudio.com/listener for privacy information.